introduction: the main objective of all organizations is to improve the efficiency and effectiveness of the personnel’s performance and this partly depends on effective management. managers are valuable assets and studying their behavior and personality dimensions may provide important guide for effectiveness and efficiency improvement. in this connection, the objective of this research is to d...

BACKGROUND Comparative effectiveness research (CER) has been proposed in the United States as a way to compare new drugs and technologies with established alternatives and determine not just whether a therapy works, but how well it works compared to other options. OBJECTIVES To define the current use of CER in the development of new drugs and technologies and explore what is needed for this r...

Background There is limited evidence detailing the cost-effectiveness of psoriasis treatments in the Asian region. Therefore, this study is aimed to evaluate the cost-effectiveness of 3 psoriasis treatments tailored for moderate to severe psoriasis, namely topical and phototherapy (TP), topical and systemic (TS), and topical and biologic (TB) regimens, respectively. Me...

Introduction: Since ancient times Malaria in Iran has been considered as a serious health risk, especially in Hormozgan Province, as no other disease like Malaria has imposed irreparable financial and life losses to the country. Since saving costs in the healthcare sector comes as first priority in most countries, this study aims at launching a cost-effectiveness analysis on malaria diagnosis d...

BACKGROUND Cost-effectiveness analysis (CEA) is used increasingly in medicine to determine whether the health benefit of an intervention is worth the economic cost. Decision trees, the standard decision modeling technique for non-temporal domains, can only perform CEA for very small problems. OBJECTIVE To develop a method for CEA in problems involving several dozen variables. METHODS We exp...

Cost-effectiveness analysis (CEA) offers decision makers a structured, rational approach with which to improve the return on resources expended. But decades after its widespread promotion to the medical community, policy makers in the United States remain reluctant to use the approach formally. Indeed, the resistance to economic evidence in the United States in an era of evidence-based medicine...

This paper discusses why, in a medical context, the standard assumption of a risk-neutral social planner is inappropriate and develops a framework for conducting cost-effectiveness (CE) analysis when social planners are risk-averse. This framework demonstrates that if new medical interventions are variance increasing (decreasing), the risk-neutral approach will approve (reject) projects that sh...